Product Information
BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1087 per EA under NDC 00591354260. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 24, 2009. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591354260
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079095FDA Approved
3/24/2009
TE Code
AB1
On Market Since
7/2/2009
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1087 per EA |
|---|---|
| All-time high | $0.5041 (Feb 12, 2014) |
| All-time low | $0.1002 (Nov 19, 2025) |
| 52-week high | $0.1380 |
| 52-week low | $0.1002 |
| Median price | $0.2203 |
| Average price | $0.2355 |
| Largest weekly change | +39.8% (May 19, 2021) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1087 per EA (NDC 00591354260), effective Aug 19, 2026.
How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 73.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?
Since Nov 28, 2013, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.1002 (Nov 19, 2025) to a high of $0.5041 (Feb 12, 2014), with a median of $0.2203 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL SR 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPROPION HCL SR 200 MG TABLET?
BUPROPION HCL SR 200 MG TABLET (NDC 00591354260) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.